Author:
Xia Zefeng,Wang Guobin,Wan Chidan,Liu Tao,Wang Shuai,Wang Bo,Cheng Rui
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Biomedical Engineering,Biomaterials,Biochemistry
Reference25 articles.
1. Lv YF. Characteristics and clinical significance of hypersplenism secondary to splenomegaly caused by cirrhotic portal hypertension. World Chin J Digestol (Chinese), 2009, 17(29):2969–2971
2. Li ZF, Zhang S. The progress and prospect of fundamental research of the spleen. J Xi’an Jiaotong Univ (Med Sci) (Chinese), 2008, 29(1):1–6
3. Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol, 2001, 13(4):317–323
4. McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Cli Gastroenterol, 2000, 14(6): 1009–1031
5. Aller MA, Vara E, Garcia C, et al. Proinflammatory liver and anti-inflammatory intestinal mediators involved in portal hypertensive rats. Mediators Inflamm, 2005,2005(2):101–111
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献